Literature DB >> 2880589

Neuronal/lymphoid membrane glycoprotein MRC OX-2 is a member of the immunoglobulin superfamily with a light-chain-like structure.

A N Barclay, M J Clark, G W McCaughan.   

Abstract

The MRC OX-2 antigen is a membrane glycoprotein of about 45,000 Mr present on rat neurons, thymocytes, B cells, follicular dendritic cells, endothelium and smooth muscle. Sequence of cDNA clones indicates it is a member of the Ig superfamily containing 248 amino acids organized like an Ig light chain with a V-like domain and a C-like domain followed by a transmembrane and cytoplasmic sections. There is a sequence with homologies with J-regions but analysis of the gene for human OX-2 shows that this is part of the V-domain exon and there is not a separate J-region exon as in the T cell receptor or Ig chains. The relationship of OX-2 to the other Ig-related neuronal/thymocyte antigen Thy-1 and the evolution of the Ig superfamily are discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2880589

Source DB:  PubMed          Journal:  Biochem Soc Symp        ISSN: 0067-8694


  34 in total

1.  Anti-angiogenic and anti-inflammatory effects of CD200-CD200R1 axis in oxygen-induced retinopathy mice model.

Authors:  Yaguang Hu; Ting Wei; Shan Gao; Qiaochu Cheng
Journal:  Inflamm Res       Date:  2019-08-23       Impact factor: 4.575

2.  The gene for MRC OX-2 membrane glycoprotein is localized on human chromosome 3.

Authors:  G W McCaughan; M J Clark; J Hurst; F Grosveld; A N Barclay
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

Review 3.  Merkel cells and touch domes: more than mechanosensory functions?

Authors:  Ying Xiao; Jonathan S Williams; Isaac Brownell
Journal:  Exp Dermatol       Date:  2014-07-16       Impact factor: 3.960

4.  CNS inflammation and neurodegeneration.

Authors:  Tanuja Chitnis; Howard L Weiner
Journal:  J Clin Invest       Date:  2017-09-05       Impact factor: 14.808

5.  CD200R1 agonist attenuates mechanisms of chronic disease in a murine model of multiple sclerosis.

Authors:  Yingru Liu; Yoshio Bando; David Vargas-Lowy; Wassim Elyaman; Samia J Khoury; Tao Huang; Karin Reif; Tanuja Chitnis
Journal:  J Neurosci       Date:  2010-02-10       Impact factor: 6.167

Review 6.  CD200-CD200R Pathway in the Regulation of Tumor Immune Microenvironment and Immunotherapy.

Authors:  Jin-Qing Liu; Aiyan Hu; Jianmin Zhu; Jianyu Yu; Fatemeh Talebian; Xue-Feng Bai
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

7.  Characterization of the human homolog of the rat MRC OX-2 membrane glycoprotein.

Authors:  G W McCaughan; M J Clark; A N Barclay
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

8.  Merkel cell carcinoma expresses the immunoregulatory ligand CD200 and induces immunosuppressive macrophages and regulatory T cells.

Authors:  Maria Rita Gaiser; Cleo-Aron Weis; Timo Gaiser; Hong Jiang; Kristina Buder-Bakhaya; Esther Herpel; Arne Warth; Ying Xiao; Lingling Miao; Isaac Brownell
Journal:  Oncoimmunology       Date:  2018-02-08       Impact factor: 8.110

9.  Understanding the neurobiology of CD200 and the CD200 receptor: a therapeutic target for controlling inflammation in human brains?

Authors:  Douglas G Walker; Lih-Fen Lue
Journal:  Future Neurol       Date:  2013-05

10.  CD200 is induced by ERK and is a potential therapeutic target in melanoma.

Authors:  Kimberly B Petermann; Gabriela I Rozenberg; Daniel Zedek; Pamela Groben; Karen McKinnon; Christin Buehler; William Y Kim; Janiel M Shields; Shannon Penland; James E Bear; Nancy E Thomas; Jonathan S Serody; Norman E Sharpless
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.